Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $7,463 - $9,225
-19 Reduced 2.05%
906 $424,000
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $2,446 - $2,676
-6 Reduced 0.64%
925 $386,000
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $19,894 - $23,819
-58 Reduced 5.86%
931 $378,000
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $1,886 - $2,111
6 Added 0.61%
989 $348,000
Q1 2023

May 10, 2023

SELL
$283.23 - $323.1 $3.3 Million - $3.77 Million
-11,653 Reduced 92.22%
983 $309,000
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $1.47 Million - $1.82 Million
-6,238 Reduced 33.05%
12,636 $3.56 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $46,055 - $54,281
-208 Reduced 1.09%
18,874 $4.93 Million
Q4 2021

Feb 15, 2022

BUY
$177.01 - $223.45 $2.18 Million - $2.75 Million
12,315 Added 181.99%
19,082 $4.19 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $70,197 - $78,557
-387 Reduced 5.41%
6,767 $1.23 Million
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $260,986 - $307,771
-1,392 Reduced 16.29%
7,154 $1.44 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $437,019 - $509,405
2,111 Added 32.8%
8,546 $1.84 Million
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $283,189 - $377,691
-1,368 Reduced 17.53%
6,435 $1.52 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $438,439 - $519,816
-1,715 Reduced 18.02%
7,803 $2.12 Million
Q2 2020

Aug 13, 2020

BUY
$225.48 - $295.8 $57,948 - $76,020
257 Added 2.78%
9,518 $2.76 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $4.34 Million - $5.38 Million
-21,700 Reduced 70.09%
9,261 $2.2 Million
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $29,007 - $38,960
174 Added 0.57%
30,961 $6.78 Million
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $325,977 - $366,883
1,961 Added 6.8%
30,787 $5.22 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $635,888 - $735,399
3,863 Added 15.47%
28,826 $5.29 Million
Q4 2018

Feb 13, 2019

BUY
$151.91 - $192.21 $3.79 Million - $4.8 Million
24,963 New
24,963 $4.14 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.